CVRx makes Barostim, an implantable device that uses electrical pulses to treat heart failure. CVRX reports earnings on Thu, Nov 5, 2026.
Prices, price targets and earnings estimates for CVRX are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plansSign in
No whale options trades in CVRX in the last 90 days.
Total alerts
0
Bullish
0
0%
Bearish
0
0%
Date span
—
Loading…
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CVRX is in one of them and how their past CVRX trades turned out.
Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.
About CVRx
CVRx makes Barostim, an implantable device that delivers electrical pulses to sensors in the wall of the carotid artery to treat heart failure with reduced ejection fraction. The device is placed in a minimally invasive outpatient procedure and is designed to work alongside standard medications. Its customers include patients with this form of heart failure, the doctors who treat them, and the healthcare payers who cover the therapy. The company is based in Minneapolis, Minnesota.
